(1991). Consensus development conference: prophylaxis and treatment of osteoporosis. The American Journal of Medicine, 90, 107-110.

Siris, E. S., Miller, P. D., Barret-Conner, E., et al. (2001). Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: Results from the National Osteoporosis Risk Assessment. JAMA, 286, 2815–2822.

Article  CAS  PubMed  Google Scholar 

National Osteoporosis Foundation. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Available from: http://www.nof.org/professionals/clinical-guidelines. Accessed 13 Jan 2011.

Cooper, C., Campion, G., & Melton, L. J., 3rd. (1992). Hip fractures in the elderly: A world-wide projection. Osteoporosis International, 2, 285–289.

Article  CAS  PubMed  Google Scholar 

Kado, D. M., Browner, W. S., Palermo, L., Nevitt, M. C., Genant, H. K., & Cummings, S. R. (1999). Vertebral fractures and mortality in older women: A prospective study. Study of Osteoporotic Fractures Research Group. Archives of Internal Medicine., 159, 1215–1220.

Article  CAS  PubMed  Google Scholar 

Melton, L. J., III. (1993). Hip fractures: A worldwide problem today and tomorrow. Bone, 14, 1–8.

Article  Google Scholar 

Meeta, M., Harinarayan, C. V., Marwah, R., Sahay, R., Kalra, S., & Babhulkar, S. (2020). Clinical practice guidelines on postmenopausal osteoporosis: Indian menopause society. Journal of Mid-life Health., 11, 96.

Article  PubMed  PubMed Central  Google Scholar 

Dhanwal, D. K., Siwach, R., Dixit, V., Mithal, A., Jameson, K., & Cooper, C. (2013). Incidence of hip fracture in Rohtak district, North India. Archives of Osteoporosis, 8(1–2), 135.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marwaha, R. K., Tandon, N., Gupta, Y., Bhadra, K., Narang, A., Mani, K., Mithal, A., & Kukreja, S. (2012). The prevalence of and risk factors for radiographic vertebral fractures in older Indian women and men: Delhi Vertebral Osteoporosis Study (DeVOS). Archives of Osteoporosis, 7, 201–207. https://doi.org/10.1007/s11657-012-0098-8. Epub 2012 Sep 18 PMID: 23225298.

Article  PubMed  Google Scholar 

Mithal, A., & Kaur, P. (2012). Osteoporosis in Asia: A call to action. Current Osteoporosis Reports, 10(4), 245–247.

Article  PubMed  Google Scholar 

Shatrugna, V., KulkarniKumar, B. P. A., et al. (2005). Bone status of Indian Women from a low income group and it’s relationship to the nutritional status. Osteoporosis International, 16, 1827.

Article  PubMed  Google Scholar 

Gupta, A. (1998). Osteoporosis in India—the nutritional hypothesis. In A. Mithal, D. S. Rao, & M. Zaidi (Eds.), Metabolic bone disorders (p. 115). Hindustani Book Depot.

Google Scholar 

Thakur, P., Kuriakose, C., Cherian, K. E., Asha, H. S., Kapoor, N., & Paul, T. V. (2020). Knowledge gap regarding osteoporosis among medical professionals in Southern India. Journal of Evaluation in Clinical Practice, 26, 272–280. https://doi.org/10.1111/jep.13164

Article  PubMed  Google Scholar 

Senthilraja, M., Cherian, K. E., Jebasingh, F. K., Kapoor, N., Paul, T. V., & Asha, H. S. (2019). Osteoporosis knowledge and beliefs among postmenopausal women: A cross-sectional study from a teaching hospital in southern India. J Family Med Prim Care, 8, 1374–1378.

Article  PubMed  PubMed Central  Google Scholar 

Vanderschueren, D., Vandenput, L., Boonen, S., Lindberg, M. K., Bouillon, R., & Ohlsson, C. (2004). Androgens and bone. Endocrine Reviews, 25, 389–425.

Article  CAS  PubMed  Google Scholar 

Albright, F., Smith, P. H., & Richardson, A. M. (1941). Postmenopausal osteoporosis: Its clinical features. JAMA, 116, 2465–2474.

Article  Google Scholar 

Gambacciani, M., Spinetti, A., Taponeco, F., Cappagli, L., & Fioretti, P. (1994). Longitudinal evaluation of perimenopaausal vertebral bone loss: Effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism. Obstetrics and Gynecology, 83, 392–396.

CAS  PubMed  Google Scholar 

Gambacciani, M., Spinetti, A., Taponeo, F., Taponeco, F., Manetti, P., Piaggesi, L., et al. (1994). Bone loss in perimenopusal women: a longitudinal study. Maturitas, 18, 191–197.

Article  CAS  PubMed  Google Scholar 

Aebi, S., Davidson, T., Gruber, G., Castiglione, M., ESMO Guidelines Working Group. (2010). Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 21(Suppl 5), v9-14.

Article  PubMed  Google Scholar 

Hadji, P. (2009). Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis. Critical Reviews in Oncology Hematology, 69, 73–82.

Article  PubMed  Google Scholar 

Hadji, P., Aapro, M. S., Body, J. J., Bundred, N. J., Brufsky, A., Coleman, R. E., Gnant, M., et al. (2011). Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: Practical guidance for prevention and treatment. Annals of Oncology, 22, 2546–2555.

Article  CAS  PubMed  Google Scholar 

Seifert-Klauss, V., Mueller, J. E., Luppa, P., Probst, R., Wilker, J., Höss C, et al. (2002). Bone metabolism during the perimenopausal transition: a prospective study. Maturitas, 41, 23–33.

Article  CAS  PubMed  Google Scholar 

Guthrie, J. R., Ebeling, P. R., Hopper, J. L., Barrett-Connor, E., Dennerstein, L., Dudley, E. C., et al. (1998). A prospective study of bone loss in menopausal Australian-born women. Osteoporosis International, 8, 282–290.

Article  CAS  PubMed  Google Scholar 

Tanko, L. B., & Christianson, C. (2006). Hormone replacement therapy. In A. R. Genazzani (Ed.), Postmenopausal osteoporosis: hormones and other therapies. Controversial issues in climacteric medicine series (pp. 186–187). CRC Press.

Google Scholar 

Khastgir, G., Studd, J., Holland, N., Alaghband-Zadeh, J., Fox, S., & Chow, J. (2001). Anabolic effects of estrogen replacement on bone replacement in postmenopausal women with osteoporosis: Histomorphometric evidence in a longitudinal study. Journal of Clinical Endocrinology and Metabolism, 86, 289–295.

CAS  PubMed  Google Scholar 

Cummings, S. R., Browner, W. S., Bauer, D., Stone, K., Ensrud, K., Jamal, S., & Ettinger, B. (1998). Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. New England Journal of Medicine., 339(11), 733–738. https://doi.org/10.1056/NEJM199809103391104. PMID: 9731089.

Article  CAS  PubMed  Google Scholar 

Forbes, A. P. (1991). Fuller Albright. His concept of postmenopausal osteoporosis and what came of it. Clinical Orthopaedics and Related Research., 269, 128–141.

Article  Google Scholar 

Marcus, R., Holloway, L., Wells, B., Greendale, G., James, M. K., Wasilauskas, C., et al. (1999). The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. Journal of Bone and Mineral Research., 14, 1583–1595.

Article  CAS  PubMed  Google Scholar 

Wells, G., Tugwell, P., Shea, B., et al. (2002). Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocrine Review, 23, 529–539.

Article  CAS  Google Scholar 

Rossouw, J. E., Anderson, G. L., Prentice, R. L., et al. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women’s Health Initiative randomized controlled trial. JAMA, 288, 321–333.

Article  CAS  PubMed  Google Scholar 

Torgerson, D. J., & Bell-Syer, S. E. M. (2001). Hormone replacement therapy and prevention of nonvertebral fractures: A meta-analysis of randomized trials. JAMA, 285(22), 2891–2897. https://doi.org/10.1001/jama.285.22.2891

Article  CAS  PubMed  Google Scholar 

Marjoribanks, J., Farquhar, C., Roberts, H., & Lethaby, A. (2012). Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database of Systematic Reviews (7), CD004143

Lorentzon, M., Johansson, H., & Harvey, N. C. (2023). Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability—results from the Women’s Health Initiative hormone therapy trials. Osteoporosis International. https://doi.org/10.1002/14651858.CD004143.pub4.Accessed24June

Article  PubMed  PubMed Central  Google Scholar 

Goldštajn, M. Š, Mikuš, M., Ferrari, F. A., Bosco, M., & U,. (2023). Effects of transdermal versus oral hormone replacement therapy in postmenopause: A systematic review. Archives of Gynecology and Obstetrics, 307(6), 1727–1745. https://doi.org/10.1007/s00404-022-06647-5

Article  CAS  PubMed  Google Scholar 

Lindsay, R., Gallagher, C., Kleerekoper, M., et al. (2002). Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. JAMA, 287, 2668–2676.

Article  CAS  PubMed  Google Scholar 

Cummings, S. R., Ettinger, B., Delmas, P. D., Kenemans, P., Stathopoulos, V., Verweij, P., Mol-Arts, M., Kloosterboer, L., Mosca, L., Christiansen, C., Bilezikian, J., Kerzberg, E. M., Johnson, S., Zanchetta, J., Grobbee, D. E., Seifert, W., & Eastell, R. (2008). LIFT Trial Investigators: The effects of tibolone in older postmenopausal women. New England Journal of Medicine, 359, 697–708. https://doi.org/10.1056/NEJMoa0800743

Article  CAS  PubMed  Google Scholar 

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists’ Collaborative Group. (1998). Lancet, 351, 1451–1467.

Grady, D., Ettinger, B., Moscarelli, E., Multiple Outcomes of Raloxifene Evaluation Investigators, et al. (2004). Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation. Obstetrics & Gynecology., 104, 837–844.

Article  CAS  Google Scholar 

Lobo, R. A., Pinkerton, J. V., Gass, M. L. S., et al. (2009). Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic bone parameters and overall safety profile. Fertility and Sterility, 92, 1025–1038.

Article  CAS  PubMed  Google Scholar 

Genant, H. K. (2011). Bazedoxifene: A new selective estrogen receptor modulator for postmenopausal osteoporosis. Menopause International, 17, 44–49.

Article  PubMed